GLENDA MEJOS: Open Payments
NPI 1346738333 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 55 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $1,194 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $409 |
| Novo Nordisk Inc | 11 | $304 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $224 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $30 |
| Dexcom, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
Products named: Kerendia, Wegovy, VRAYLAR, UBRELVY, QULIPTA, FARXIGA, PAXLOVID, MOUNJARO.
Industry payments across TX — which companies pay providers there.
